'Pancreatic Cancer Deaths IncreasingThese recent treatment advances are long overdue. Although deaths from most malignancies are declining, pancreatic cancer moved from the fourth leading cause of cancer death to the third in 2016, surpassing breast cancer. The population is growing older and living longer, and innovative new therapies have largely passed this tumor by, Dr. Tempero said. The vast majority of patients with pancreatic cancer are diagnosed with advanced unresectable disease; most patients experience relapse after treatment. Furthermore, the “cure rate” for this disease is only 9%, and without treatment, the median survival of patients with metastatic disease is only 3 months.“This is a very tough disease,” Dr. Tempero noted. “There are no early symptoms, the tumor invades and metastasizes early, it is somewhat chemotherapy-resistant, and patients suffer from debilitating cytokine-mediated symptoms.' https://jnccn.org/view/journals/jnccn/17/5.5/article-p603.xml
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil AGM CEO Presentation
Ann: OncoSil AGM CEO Presentation, page-96
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $45.40M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.2¢ | $137.7K | 11.46M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1719369 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3242606 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1719369 | 0.012 |
18 | 8543559 | 0.011 |
19 | 10448091 | 0.010 |
9 | 3811222 | 0.009 |
3 | 560000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3242606 | 5 |
0.014 | 6510508 | 12 |
0.015 | 5072540 | 15 |
0.016 | 4292825 | 6 |
0.017 | 5155548 | 3 |
Last trade - 15.10pm 18/10/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |